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Abstract Although trauma-focused cognitive behavioral
therapy (TF-CBT) with exposure is an effective treatment
for posttraumatic stress disorder (PTSD), not all patients
recover. Addition of breathing biofeedback to exposure in
TF-CBT is suggested as a promising complementary
technique to improve recovery of PTSD symptoms.
Patients (n = 8) with chronic PTSD were randomized to
regular TF-CBT or TF-CBT with complementary breathing
biofeedback to exposure. PTSD symptoms were measured
before, during and after TF-CBT with the Impact of Event
Scale-Revised. The results show that breathing biofeed-
back is feasible and can easily be complemented to TF-
CBT. Although PTSD symptoms significantly decreased
from pre to post treatment in both conditions, there was a
clear trend towards a significantly faster (p = .051)
symptom reduction in biofeedback compared to regular
TF-CBT. The most important limitation was the small
sample size. The hastened clinical improvement in the
biofeedback condition supports the idea that breathing
biofeedback may be an effective complementary compo-
nent to exposure in PTSD patients. The mechanism of
action of breathing biofeedback may relate to competing
working memory resources decreasing vividness and
emotionality, similar to eye movement desensitization and
reprocessing. Future research is needed to examine this.
Keywords Posttraumatic stress disorder (PTSD) 
Breathing biofeedback  Trauma-focused cognitive
behavioral therapy (TF-CBT)  Working memory
Introduction
With 80 % of the general Dutch population experiencing a
traumatic event once in their life (de Vries and Olff 2009)
and 7–9 % developing a posttraumatic stress disorder
(PTSD; Kessler et al. 1995; de Vries and Olff 2009) opti-
mal treatment should be available for patients suffering
from this disorder. Until now, ‘‘trauma-focused’’ treat-
ments, such as eye movement desensitization and repro-
cessing (EMDR) and trauma-focused cognitive behavioral
therapy (TF-CBT) have been shown to be equally effective
in reducing PTSD symptoms (Bisson and Andrew 2007;
Nijdam et al. 2012; Bradley et al. 2005; Seidler and
Wagner 2006). One of the key elements in TF-CBT, is
prolonged exposure (PE), in which patients are asked to
relive their trauma by telling about it in detail.
Although TF-CBT and EMDR both can reduce trau-
matic stress symptoms, not all patients recover (Bisson and
Andrew 2007). Furthermore, previous studies show sig-
nificant rates of non-response (Schottenbauer et al. 2008)
and drop-out (Nijdam et al. 2012; Schnurr et al. 2007). This
may relate to difficulties in fully engaging during exposure,
due to resistance of the patient to become highly distressed,
or even engaging in therapy (not showing up during the
sessions or eventually drop-out). As engaging during the
session is essential for exposure to be efficacious and for
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habituation to occur, it may be helpful to add comple-
mentary elements or techniques, that may decrease resis-
tance and increase tolerance to distress.
Biofeedback treatment may be a promising comple-
mentary treatment of CBT to further improve PTSD
symptom recovery. During biofeedback, patients receive
feedback from changes in physiological activity (i.e., heart
rate variability or breathing). This technique can be im-
plemented in treatment as usual. For example, breathing
biofeedback as an adjunct to imaginal exposure therapy
may entail breathing at a certain pace during imagining the
traumatic event. By adding a biofeedback component, such
as breathing biofeedback, exposure treatment may be better
manageable for PTSD patients and result in better
engagement. Especially during the first sessions, when
symptoms may temporarily increase, adding this breathing
component during exposure may decrease distress and in-
duce engagement, consequently resulting in habituation.
Another possibility is that additional breathing biofeedback
is a competing working memory resource that conse-
quently leads to less vivid and emotional images and
thereby decreases PTSD symptoms, similarly as shown in
other tasks taxing working memory (van den Hout et al.
2011a, b).
The effects of various types of biofeedback as an adjunct
to regular psychological treatment have previously been
investigated. For example, studies of depressed patients
reported a reduction in depressive symptoms (Karavidas
et al. 2007) as well as anxiety symptoms (Siepmann et al.
2008; Karavidas et al. 2007). Particularly in anxiety dis-
orders, for which physiological arousal is eminent, an in-
creasing number of studies report positive results of various
forms of biofeedback added to CBT, e.g. heart rate vari-
ability (HRV) biofeedback and respiratory sinus arrhyth-
mia (RSA) in panic disorder (Meuret et al. 2004) and
particularly in PTSD (Gevirtz and Dalenberg 2008; Morina
et al. 2012).
Previous RCTs in PTSD patients have shown to be ef-
fective in decreasing PTSD specific symptoms (Tan et al.
2011) as well as comorbid depressive symptoms (Zucker
et al. 2009) with additional HRV and RSA biofeedback
treatment, respectively. Additional beneficial effects of
biofeedback over and above the effects of CBT alone, were
however not confirmed in another trial (Lande et al. 2010)
since there was no significant difference in the decrease of
PTSD symptoms between the HRV biofeedback condition
and treatment as usual. Thus far, results are limited and
inconclusive. In these previous studies, the biofeedback
procedure was offered by separate and more time con-
suming extra sessions with biofeedback, though it would be
more informative to examine feasibility and the course of
PTSD symptoms when biofeedback is implemented di-
rectly into the session with the treatment as usual. This type
of research would add useful information and may be
helpful in drawing further conclusions on the effectiveness
of biofeedback adjunct to CBT.
The aim of this pilot study, therefore, was to investigate
the feasibility of breathing biofeedback when it is imple-
mented as a direct adjunct to the exposure element within
CBT sessions and to examine whether this leads to a sig-
nificant pre to post treatment decrease of PTSD symptoms.
By comparing the regular TF-CBT with the TF-
CBT ? biofeedback treatment, we aim to explore whether
the addition of breathing biofeedback to exposure in CBT,
further modifies symptom reduction by promoting en-
gagement or distraction during exposure.
Based on previous studies (Zucker et al. 2009; Lande
et al. 2010), we hypothesize that both breathing biofeed-
back and treatment as usual will lead to a significant de-
crease of PTSD symptoms when compared to pre treatment
PTSD symptoms. Most interestingly, we expect a differ-
ence between conditions on PTSD symptom reduction, i.e.,
larger PTSD symptom reduction in the biofeedback con-
dition than regular TF-CBT condition, as is consistent with
a previous study (Tan et al. 2011).
Methods
Participants
Patients with chronic PTSD from an outpatient clinic of the
Academic Medical Center (AMC) were invited to par-
ticipate in the study. PTSD was diagnosed by an experi-
enced clinician using the Clinician-Administered PTSD
Scale (CAPS; Blake et al. 1995). Patients with a CAPS
score of 45 or more were included in the study. Patients
were excluded when other axis I disorders were present
using the Mini-International Neuropsychiatric Interview
(M.I.N.I-Plus; Sheehan et al. 1998). The Hamilton De-
pression Rating Scale (HDRS; Hamilton 1960) and clinical
impression of the medical expert were used to measure the
severity of comorbid depression. Patients were excluded in
case of comorbid severe depressive disorder and when
additional pharmacotherapy to TF-CBT was indicated.
Patients taking psychotropic drugs were also excluded.
After informed consent, patients were randomized to either
the control condition in which they received treatment with
TF-CBT or to the biofeedback condition in which exposure
similar to the regular TF-CBT group was combined with
breathing biofeedback. TF-CBT consisted of weekly ses-
sions with exposure as the key element. The biofeedback
group also received TF-CBT with breathing biofeedback
complemented to exposure. Both groups received therapy
sessions given by therapists that were part of the clinical
workers of our department. They all had clinical
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experience and at least a Master’s degree in Clinical Psy-
chology. Furthermore, they all had followed a training for
TF-CBT at our department, in order to properly execute the
clinician manual. The therapists received supervision
regularly (once a month).
Of the nine patients that met the in- and exclusion criteria,
eight (6 females and 2 males) were included (one patient
declined). Participants experienced single-event traumata
such as motor vehicle accidents, sexual or physical abuse.
Their median age was 45 years (with a range of 25–57).
Total number of sessions over time differed within the
sample, median number of sessions was 7.5 (with a range
between 5 and 18 sessions), of which all but one patient
responded within the range of 8–12 sessions, consistent with
the guidelines of CBT (Creamer et al. 2004).
Materials and Procedure
All patients were randomized to treatment as usual con-
sisting of TF-CBT (TAU condition) or to TF-CBT with an
adjunct of biofeedback (biofeedback condition). TF-CBT
was based on the model original developed by Foa et al.
(1995) for female victims of rape. For TF-CBT, a strict
protocol was used (Creamer et al. 2004), that included
exposure (imaginal and in vivo) as its key element. Other
elements were psycho-education and anxiety management.
For more details concerning the protocol, see elsewhere
(Polak et al. 2012). When randomized to the biofeedback
condition, the breathing biofeedback device was introduced
during the first (psycho-education) session. The introduc-
tion consisted of instructions for the use and practice dur-
ing the session. A homework assignment following the first
session included every day practice with the breathing
biofeedback device when in relaxed state, which was
expected to be sufficient to get comfortable with the device
in order to be able to use the device during imaginal ex-
posure in the sessions. From session three on (concurrent
with start of focusing on hotspots, i.e., one or more emo-
tional climaxes in the event that evoked the most fear or
other emotional arousal) patients were instructed to use
breathing biofeedback when focusing on a hotspot during
imaginal exposure.
The biofeedback device selected for the study was the
RespiFit and was provided by the University of Amsterdam
(UvA) and the Dutch Institute for Scientific Research and
Breathing Regulation and Health Advancement (Nederlands
Instituut voor Wetenschappelijk Onderzoek naar Adem-
regulatie en Gezondheidsbevordering; NIAG). The breath-
ing device measured the breathing frequency per minute. As
mentioned previously, the breathing biofeedback device was
introduced during the first (psycho-education) session. The
introduction consisted of instructions for the use and practice
during the session in order to familiarize the patient with the
breathing component. The breathing frequency was pro-
grammed in advance. The device provided immediate
feedback by a beep sound through an earplug. The device
monitored whether the breathing followed the rhythm of the
programmed breathing frequency. When the breathing fre-
quency did not follow the breathing frequency anymore,
sounds were offered as a sign that the patient should adjust
the breathing frequency. When patients were breathing fol-
lowing the exact breathing rhythm, no sounds were offered
anymore. During the actual therapy sessions, the procedure
of the biofeedback device was implemented in the exposure
element of TF-CBT and used when focusing on a traumatic
hotspot. This procedure was similar for all patients.
Feasibility was assessed based on the ease of instructing
patients and implementing it in the session. Furthermore,
treatment adherence was assessed by keeping a record of
attendance to the sessions, completion of homework as-
signments as well as treatment completion.
The main outcome measure consisted of the Impact of
Event Scale-Revised (IES-R; Weiss and Marmar 1997) to
measure PTSD symptoms. The IES-R is a 22-item self-re-
port measure (with five point Likert scales, 0–4) that
assesses subjective distress caused by traumatic events and
is known as a solid measure of posttraumatic symptoms that
is used often in clinical as well as research settings (Beck
et al. 2008). Items correspond directly to 14 of the 17 DSM-
IV symptoms of PTSD and all three symptom clusters [re-
experiencing (8 items, scale range 0–32), avoidance (8
items, range 0–32) and hyper arousal (6 items, range 0–24)].
High levels of internal consistency have been previously
reported (intrusion: Cronbach’s alpha = .87–.94, avoid-
ance: Cronbach’s alpha = .84–.87, hyper arousal: Cron-
bach’s alpha = .79–.91; Weiss and Marmar 1997). Test–
retest reliability, collected across a 6-month interval, ranged
from .89 to .94 (Weiss and Marmar 1997). The IES-R was
assessed at baseline (i.e., pre treatment), at each weekly
session and at follow-up (i.e., 1 week post treatment).
The number of sessions was based on the Subjective
Units of Distress (SUDS), a rating system on a 100-point
scale ranging from 0 (no anxiety) to 100 (extreme anxiety).
When the SUDS appeared to have dropped (below 0–30),
showing that the patient did not experience extreme anxiety
anymore while imagining the traumatic event, the therapy
was completed.
Statistical Analyses
Baseline differences on demographic and clinical charac-
teristics between the biofeedback group and the TAU
group were calculated using the non-parametric Mann–
Whitney U-test for continuous variables. Fisher’s exact
tests for small samples were used to assess ordinal
variables.
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Linear mixed-effects models with restricted maximum
likelihood estimation and a fixed effect intercept were used
to test whether the conditions (biofeedback and TAU)
showed a differential effect on PTSD symptoms (IES-R)
from pre to post treatment assessment. We also tested a
mixed model with a Time factor consisting of the weekly
IES-R scores instead of only the pre and post treatment
assessment (T0 and T1). Although some patients received
more sessions, we used 9 sessions in the model, as the
majority of patients did not need more than 9 sessions. A
mixed model is preferable over repeated measures
ANOVA because it can handle missing values and mea-
surements taken at unequival intervals. Thus, missing data
were not replaced but handled in the mixed model. The
mixed models included Time, Condition and an interaction
between Time and Condition as within-subjects factors.
The error structure of repeated measures was modeled as
AR1 because correlation between measurements decreases
as time points get further apart. We controlled for the
baseline measurement (T0) for IES-R scores. All analyses
were conducted using PASW version 19.0. Statistic Soft-
ware Package (SPSS, Chicago, Illinois).
Results
Demographics and clinical characteristics of all par-
ticipants are depicted in Table 1.
Breathing biofeedback appeared to be an easy to instruct
and to implement procedure that can be complemented to
TF-CBT. It was easy to instruct as patients were able to
grasp the procedure with the short instruction in the first
session and were able to follow the procedure during the
prolonged exposure while focusing on the hotspot. The
breathing exercise showed not to obstruct the patient to
remain fully engaged in exposure to the traumatic event;
they were able to experience high anxiety that dropped
during and over the sessions. Furthermore, treatment ad-
herence, i.e., attending sessions and performing homework
was good, with all patients receiving biofeedback treatment
attending all sessions, whereas from the patients receiving
regular treatment, one patient did not attend one session.
Consequently, the IES-R score was not filled out and was
coded as missing. Another patient that was randomized to
the control condition, did not respond to the treatment and
was lost to treatment and therefore, the trial measurements
after session 5 were missing. In this case, IES-R scores in
these missing sessions were coded as missing values in the
model.
Completion rates showed that all patients receiving
biofeedback completed therapy within a reasonable num-
ber of sessions (median 7.5; min–max 6–11), in line with
the guidelines of TF-CBT, i.e., 8–12 sessions (Creamer
et al. 2004). In the TAU condition, the number of sessions
was somewhat higher (median 8.0; min–max 5–18).
Number of sessions completed is also depicted in Table 1.
The mean PTSD symptom scores for each condition at
baseline and post treatment as well as per weekly session
are depicted in Fig. 1. The mixed model analysis yielded
an effect for Time (F = 5.41; df = 8, p \ .001), a trend for
Condition (F = 4.84; df = 1, p = .061) and a borderline
significant interaction for Time 9 Condition (F = 2.32;
df = 8, p = .051). Although PTSD symptoms decreased
over time for both conditions, PTSD symptom scores de-
creased faster (with borderline statistical significance) over
time in the biofeedback condition.
Discussion
This pilot study shows that breathing biofeedback is a
feasible technique that can efficiently and safely be im-
plemented during exposure therapy in PTSD patients, as it
is easy to instruct to patients and easy to apprehend by
patients during sessions. This is in accordance with the
results of previous studies, showing that other forms of
adjunct biofeedback are feasible and could efficiently and
safely be implemented to CBT (Morina et al. 2012; Gevirtz
and Dalenberg 2008). Most importantly, the breathing ex-
ercise showed not to obstruct the patient to remain fully
engaged in exposure to the traumatic event. Notwith-
standing the small sample size, a trend was clearly no-
ticeable between conditions in favor of the biofeedback
condition. More specifically, although in both conditions a
significant reduction of symptoms from pre to post treat-
ment was found, the current results show that breathing
biofeedback addition exerted an additional effect through a
clinically (though borderline statistically) significant faster
decrease of PTSD symptoms compared to treatment as
usual (TF-CBT). Interestingly, symptom decrease in the
biofeedback condition occurred concurrently with the im-
plementation of biofeedback from session 3 on (when fo-
cusing on the hotspots), and the differences between groups
were more pronounced following session 3. This further
suggests that it is likely that it is the biofeedback addition
to the exposure element that leads to a greater decrease in
PTSD symptoms. In this respect, we must note that the
results may underestimate the actual additional effect of
biofeedback, as we included session 1 and 2 in the ana-
lyses, despite the fact that biofeedback was not imple-
mented yet and we only analyzed the first 9 sessions, while
patients not receiving biofeedback needed more sessions. A
beneficial and additional effect of biofeedback to TF-CBT
compared to regular TF-CBT, is in line with previous
studies of other forms of biofeedback in PTSD patients
(Zucker et al. 2009; Lande et al. 2010; Tan et al. 2011). A
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similar faster symptom reduction was previously found in
RSA biofeedback on depressive symptoms in PTSD pa-
tients as well (Zucker et al. 2009).
Several working mechanisms may be responsible for the
faster PTSD symptom reduction in the biofeedback con-
dition. First of all, the breathing component may function
as relaxation, thereby directly decreasing distress and in
turn inducing engagement. Indeed, previous studies support
that relaxation techniques, though not advised to use as a
stand-alone treatment, may to some extent decrease PTSD
symptoms (Hickling et al. 1986). The beneficial effect in
studies that combine biofeedback exposure (Morina et al.
2012) may be due to the combination of the effective
component of exposure and the relaxation effect of
biofeedback, resulting in less distress and induced en-
gagement, and consequently a faster decrease of symptoms
than exposure or biofeedback alone. Another factor that is
likely to contribute even more to the reduction of PTSD
symptoms may relate to the underlying working mechan-
ism of biofeedback, namely focusing on breathing while
imagining the traumatic event, may be similar to that of eye
movement desensitization and reprocessing (EMDR). In
EMDR, the patient has to perform eye movements while
imagining the traumatic event. EMDR is shown to be an
effective treatment in decreasing PTSD symptoms, and
shows a faster reduction of symptoms in comparison with
CBT (Nijdam et al. 2012; Ironson et al. 2002). The cur-
rently supported working mechanisms of EMDR suggest
that competing working memory tasks such as eye move-
ments may be important in reducing vividness and emo-
tionality (van den Hout et al. 2001). Furthermore, a recent
study (Engelhard et al. 2010) suggests that vividness and
emotionality may be reduced due to competing working
memory resources. Moreover, not only eye movements but
also other taxing tasks than eye movements may reduce the
vividness of the images, such as the computer game
‘‘tetris’’ (Engelhard et al. 2010), beeps (van den Hout et al.
2011b), calculating (Kemps and Tiggemann 2007) and
drawing a complex figure (Gunter and Bodner 2008).
Breathing biofeedback may be one of these taxing tasks as
well, that may lead to a reduction in vividness and con-
secutively a reduction in PTSD symptoms. This hypothesis
is supported in a recent study (van den Hout et al. 2011a),
in which attentional breathing is suggested to tax working
memory and reduces vividness of negative images in
healthy individuals. Although we do not have any data on
the vividness of the images, the attentional breathing in the
current study likewise also may have reduced the vividness
of negative images in PTSD patients. This mechanism of
action in complementary breathing biofeedback may ex-
plain the faster symptom improvement when attentional
breathing was added. This is also in line with other trials
with PTSD patients showing a faster symptom reduction in
EMDR in comparison with CBT (Nijdam et al. 2012;
Ironson et al. 2002).
An important limitation of this study was the small
sample size and therefore our results need to be interpreted
with caution. In this respect, the missing values of one
patient that was lost to follow-up measurement, is another
drawback. Furthermore, our results are limited by the fact
that breathing rates or parameters were not recorded during
and over sessions in neither condition. This is particularly
relevant knowing that changes in HRV and breathing do
occur when symptoms in PTSD patients subside (Zucker
et al. 2009), which was also the case in the control con-
dition. Nevertheless, all patients in the TF-CBT biofeed-
back changed their breathing upon the feedback of the
Table 1 Demographic and
clinical characteristics of
participants (biofeedback and
control condition) at baseline
and number of sessions
a Mann–Whitney test was used
for continuous variables. Chi
square tests were used for
categorical variables
b Fisher’s exact test
Biofeedback Control Test statistica P
N Median Min–max N Median Min–max
Age, years 4 46.5 25–57 4 43.0 28–53 U = 7.00
Z = -.29
.89
Female (n, %) 4 4 (100 %) 4 2 (50 %) v2 = 2.67
df = 1
.43b
IES-R 4 45 28–62 4 41.5 21–73 U = 7.00
Z = -.29
.89


















































Fig. 1 IES-R scores for biofeedback and exposure alone conditions
over time
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breathing device and this suggests that breathing biofeed-
back was the most important component for the faster
symptom reduction found.
We believe our findings may be clinically relevant. First
of all, only a limited number of controlled studies have
been done with adjunctive therapeutic elements to regular
treatment. While the feasibility of some biofeedback
techniques, like RSA biofeedback and HRV biofeedback,
have been studied before, this is to our knowledge the first
study that focused on the feasibility of breathing biofeed-
back in PTSD patients. Based on the feasibility and the
faster symptom improvement, even in this small sample
size, it may be concluded that breathing biofeedback is a
valuable complementary technique to regular TF-CBT.
Future research with larger sample sizes however, could
draw more definite conclusions on the effectiveness of
breathing biofeedback addition to exposure in CBT and the
effect on reduction in no shows and non-response in TF-
CBT. Also, looking more closely into the underlying acute
physiological processes and changes during breathing
biofeedback may gain more insight in the exact working
mechanisms involved and may provide useful directions to
further improve the efficiency of this additional treatment.
Future research should also examine whether adding at-
tentional breathing to regular TF-CBT even without
biofeedback would result in greater tolerance or effec-
tiveness of exposure sessions.
In conclusion, our pilot study shows faster clinical im-
provement in PTSD patients receiving additional atten-
tional breathing biofeedback. Attentional breathing
biofeedback has shown a promising adjunctive element for
trauma-focused CBT that can be easily implemented in
clinical practice and used as a strategy for increasing effi-
cacy of PTSD treatment.
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